+ Site Statistics
+ Search Articles
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ PDF Full Text
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Translate
+ Recently Requested

Frailty and Parkinson's disease: theories and clinical implications

Frailty and Parkinson's disease: theories and clinical implications

Parkinsonism and Related Disorders 14(4): 271-272

(PDF emailed within 0-6 h: $19.90)

Accession: 053297210

Download citation: RISBibTeXText

PMID: 18063404

DOI: 10.1016/j.parkreldis.2007.10.005

Related references

Frailty in Parkinson's disease and its clinical implications. Parkinsonism and Related Disorders 14(4): 334-337, 2007

An experimental model of Parkinson disease caused by a neurotoxin: implications in the clinical aspects and the etiology of Parkinson disease. Medicina Clinica 94(15): 585-595, 1990

Association between early-onset Parkinson disease and 22q11.2 deletion syndrome: identification of a novel genetic form of Parkinson disease and its clinical implications. JAMA Neurology 70(11): 1359-1366, 2014

Identifying frailty: do the Frailty Index and Groningen Frailty Indicator cover different clinical perspectives? a cross-sectional study. Bmc Family Practice 14: 64, 2013

Concurrence of Frailty and Parkinson's Disease. Journal of Frailty and Aging 1(3): 123-127, 2012

Clinical implications of Parkinson's disease genetics. Seminars in Neurology 26(5): 492-498, 2006

Physical Activity across Frailty Phenotypes in Females with Parkinson's Disease. Journal of Aging Research 2012: 468156, 2012

Parkinson's disease: acquired frailty of archaic neural networks?. Journal of the Neurological Sciences 314(1-2): 143-151, 2012

Survey on general knowledge on Parkinson's disease in patients with Parkinson's disease and current clinical practice for Parkinson's disease among general neurologists from Southwest China. Clinical Neurology and Neurosurgery 118: 16-20, 2014

Parkinson's disease following hypothyroidism: clinical and therapeutic implications. La Tunisie Medicale 91(2): 168-170, 2013

The heterogeneity of Parkinson's disease: clinical and prognostic implications. Neurology 35(4): 522-526, 1985

α-Synuclein oligomers and clinical implications for Parkinson disease. Annals of Neurology 73(2): 155-169, 2013

Daily electromyography in females with Parkinson's disease: a potential indicator of frailty. Archives of Gerontology and Geriatrics 58(1): 80-87, 2014

Reward pathways in Parkinson's disease: clinical and theoretical implications. Psychiatry and Clinical Neurosciences 62(2): 203-213, 2008

Clinical implications of gene discovery in Parkinson's disease and parkinsonism. Movement Disorders 25 Suppl 1: S15-S20, 2010